BioAge Labs, Inc

$4.52
(as of Jun 13, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for BioAge Labs, Inc

Stock Price
$4.52
Ticker Symbol
BIOA
Exchange
NASDAQ

Industry Information for BioAge Labs, Inc

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Company Description for BioAge Labs, Inc

Website
https://bioagelabs.com
Country
USA
Full Time Employees
62

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Fundamentals for BioAge Labs, Inc

Market Capitalization
$674,118,848
EBITDA
$-51,394,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-5.40
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
34,167,200
Percent Owned by Insiders
3.80%
Percent Owned by Institutions
32.64%
52-Week High
52-Week Low

Technical Indicators for BioAge Labs, Inc

50-Day Moving Average
200-Day Moving Average
RSI
64.36
ATR
0.22

Analyst Ratings for BioAge Labs, Inc

Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
1

News About BioAge Labs, Inc

May 27, 2025, 4:30 PM EST
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. See more.
May 21, 2025, 9:00 PM EST
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BioAge Labs, Inc. See more.
Apr 24, 2025, 8:28 AM EST
PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- See more.
Apr 22, 2025, 8:13 AM EST
PHILADELPHIA, April 22, 2025 (GLOBE NEWSWIRE) -- See more.